The Not-So-Melting Pot: Workforce and Patient Research Inequity Caps Genomic Medicine Progress

Abstract

Inside Precision MedicineVol. 9, No. 6 Issue FocusThe Not-So-Melting Pot: Workforce and Patient Research Inequity Caps Genomic Medicine ProgressImportant scientific, governmental, and technical issues have stymied diversity among patients and researchers involved in genetic medicine, restricting the medical benefits for underrepresented groupsJonathan D. GrinsteinJonathan D. GrinsteinJonathan D. Grinstein's wonder for the human mind and body led him to an undergraduate education in Neural Science and Philosophy and a doctorate in Biomedical science. He has 10 years of experience in experimental and computational research, during which he was a co-author on research articles in journals such as Nature and Cell. Since then, Jonathan hung up his lab coat and has explored positions in science writing and editing. Jonathan's science writing work has been featured in Scientific American, Genetic Engineering and Biotechnology News (GEN), and NEO.LIFE.Search for more papers by this authorPublished Online:9 Jan 2023https://doi.org/10.1089/ipm.09.06.07AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 9Issue 6Dec 2022 InformationCopyright © GEN PublishingTo cite this article:Jonathan D. Grinstein.The Not-So-Melting Pot: Workforce and Patient Research Inequity Caps Genomic Medicine Progress.Inside Precision Medicine.Dec 2022.34-38.http://doi.org/10.1089/ipm.09.06.07Published in Volume: 9 Issue 6: January 9, 2023PDF download